全文获取类型
收费全文 | 5466篇 |
免费 | 363篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 163篇 |
妇产科学 | 268篇 |
基础医学 | 652篇 |
口腔科学 | 119篇 |
临床医学 | 565篇 |
内科学 | 1037篇 |
皮肤病学 | 52篇 |
神经病学 | 951篇 |
特种医学 | 284篇 |
外科学 | 576篇 |
综合类 | 74篇 |
预防医学 | 412篇 |
眼科学 | 49篇 |
药学 | 382篇 |
肿瘤学 | 235篇 |
出版年
2021年 | 75篇 |
2019年 | 46篇 |
2018年 | 67篇 |
2017年 | 48篇 |
2016年 | 44篇 |
2015年 | 72篇 |
2014年 | 109篇 |
2013年 | 154篇 |
2012年 | 201篇 |
2011年 | 234篇 |
2010年 | 166篇 |
2009年 | 157篇 |
2008年 | 212篇 |
2007年 | 201篇 |
2006年 | 211篇 |
2005年 | 201篇 |
2004年 | 180篇 |
2003年 | 162篇 |
2002年 | 161篇 |
2001年 | 159篇 |
2000年 | 166篇 |
1999年 | 135篇 |
1998年 | 88篇 |
1997年 | 83篇 |
1996年 | 66篇 |
1995年 | 77篇 |
1994年 | 82篇 |
1993年 | 49篇 |
1992年 | 155篇 |
1991年 | 141篇 |
1990年 | 144篇 |
1989年 | 159篇 |
1988年 | 151篇 |
1987年 | 166篇 |
1986年 | 140篇 |
1985年 | 127篇 |
1984年 | 104篇 |
1983年 | 78篇 |
1982年 | 68篇 |
1981年 | 52篇 |
1980年 | 52篇 |
1979年 | 85篇 |
1978年 | 69篇 |
1977年 | 47篇 |
1976年 | 57篇 |
1975年 | 50篇 |
1974年 | 37篇 |
1973年 | 40篇 |
1972年 | 54篇 |
1970年 | 37篇 |
排序方式: 共有5854条查询结果,搜索用时 15 毫秒
101.
A Miller A Khosla J Lynch J Moreb S Cullins H Safah C Hutchison V La Russa Veins J Rice N Mendenhall R Weiner 《Medical oncology (Northwood, London, England)》1998,15(2):89-95
We treated 20 women with locally advanced breast cancer between January 1991 and September 1996, The treatment regimen included
4 cycles of intensive doxorubicin (30 mg/m2/ d on 3 consecutive days every 2 weeks with G-CSF support), followed by appropriate
surgery, followed by high dose therapy with cyclophosphamide, carboplatin and thiotepa (STAMP V, CTCb). Of the 20 patients,
seven presented with inflammatory breast cancer, three with Stage HIB, seven with stage IIIA, one with multifocal Stage IIB
and two with Stage IV M1 (ipsilateral supraclavicular lymph node involvement) (including one who had an inflammatory primary)
disease. Six patients had not undergone mastectomy at the time of entering the protocol. These six received the doxorubicin
in a neoadjuvant fashion and were thus evaluable for tumor response. The remaining 14 received doxorubicin as adjuvant therapy
prior to intensification and transplantation. All patients underwent local-regional radiation therapy and were placed on oral
tamoxifen. Doxorubicin was well tolerated in this schedule with ali but three patients receiving all their cycles on schedule.
Both BM and PBPC were easily collected after this regimen and, when reinfused, resulted in the prompt recovery of granulocytes
(median 11 days to 500 absolute granulocyte count) and platelets (median 13 days to 20000 platelets). The six patients who
received doxorubicin prior to mastectomy all had major clinical responses, but were found to have microscopic focii of breast
cancer in the mastectomy specimens. The overall treatment was well tolerated with the exception of one treatment-related death
(5%). The overall and relapse free survival are 70% and 58% respectively with a median follow-up of 40 months (range 12–74
months). When the Stage IV patients are censored, the relapse-free survival rate is 69%. In the bone marrow transplant phase
of treatment, the major non-hematologic toxicities were stomatitis (70%) and anorexia requiring parental nutrition (75%). 相似文献
102.
Sandra Bond Chapman Myron F Weiner Audette Rackley Linda S Hynan Jennifer Zientz 《J. Speech Lang. Hear. Res.》2004,47(5):1149-1163
This randomized study evaluated the combined effect of a cognitive-communication program plus an acetylcholinesterase inhibitor (donepezil; donepezil-plus-stimulation group; n = 26), as compared with donepezil alone (donepezil-only group; n = 28) in 54 patients with mild to moderate Alzheimer's disease (AD; Mini-Mental Status Examination score of 12- 28) ranging in age from 54 to 91 years. It was hypothesized that cognitive-communication stimulation in combination with donepezil would positively affect the following: (a) relevance of discourse, (b) performance of functional abilities, (c) emotional symptoms, (d) quality of life, and (e) overall global function, as measured by caregiver and participant report and standardized measures. Cognitive-communication, neuropsychiatric, functional performance, and quality of life evaluations were conducted at baseline and Month 4, the month after the 2-month active stimulation period. Follow-up evaluations were performed at Months 8 and 12. The stimulation program consisted of 12 hr of intervention over an 8-week period and involved participant-led discussions requiring homework, interactive sessions about AD, and discussions using salient life stories. Additive effects of active stimulation with donepezil were examined in 2 ways: (1) comparing mean group performance over time and (2) evaluating change scores from baseline. A Group x Time interaction was found for the donepezil-plus-stimulation group in the emotional symptoms of apathy and irritability as compared with the donepezil-only group. Evaluation of change scores from baseline to 12 months revealed a positive effect for the donepezil-plus-stimulation group on discourse and functional abilities with a trend on apathy, irritability, and patient-reported quality of life. In sum, the research revealed benefits to the donepezil-plus-stimulation group in the areas of discourse abilities, functional abilities, emotional symptoms, and overall global performance. This study adds to growing evidence that active cognitive stimulation may slow the rate of verbal and functional decline and decrease negative emotional symptoms in AD when combined with acetylcholinesterase inhibitors, indicating a need to advance research in the area of cognitive treatments. The fact that AD is a progressive brain disease should not preclude ameliorative treatment. 相似文献
103.
B Jahrsd?rfer J E Wooldridge S E Blackwell C M Taylor B K Link G J Weiner 《Leukemia》2005,19(5):759-766
Chromosomal abnormalities in B-cell chronic lymphocytic leukemia (B-CLL) have been shown to correlate with prognosis. Little is known about the relationship between chromosomal abnormalities and biological behavior of B-CLL cells in vitro. The present study was designed to explore the impact of chromosomal abnormalities determined by interphase fluorescence in situ hybridization (FISH) on the in vitro survival and immunogenicity of B-CLL. Considerable heterogeneity was noted in the in vitro survival and expression of costimulatory, adhesion, and antigen-presenting molecules by B-CLL cells. Spontaneous apoptosis of B-CLL cells in vitro was significantly lower in samples with good prognosis cytogenetics when compared to samples with poor prognosis cytogenetics. In contrast, B-CLL cells from samples with good prognosis cytogenetics exhibited higher basal expression of molecules involved in costimulation, cellular adhesion, and antigen presentation, and induced significantly more T-cell proliferation in mixed lymphocyte cultures. We conclude that chromosomal aberrations of B-CLL cells correlate with the in vitro biological behavior of B-CLL. Our data indicate that good prognosis cytogenetics correlates with less spontaneous apoptosis but greater in vitro immunogenicity. These findings could have significant implications on the design of future therapeutic approaches in patients with CLL, and the likelihood of response based on cytogenetics. 相似文献
104.
Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. 总被引:4,自引:0,他引:4
Adam C Berger Jeffrey Farma Walter J Scott Gary Freedman Louis Weiner Jonathan D Cheng Hao Wang Melvyn Goldberg 《Journal of clinical oncology》2005,23(19):4330-4337
PURPOSE: Attempts to improve survival of patients with esophageal cancer have been made using induction chemoradiotherapy (CRT) followed by surgery. A large single-center experience was reviewed to determine which treatment-related variables could predict survival and recurrence. PATIENTS AND METHODS: All patients undergoing esophagectomy between January 1994 and December 2002 were reviewed. Univariate and multivariate analyses were performed using log-rank and Cox proportional hazards models, and survival curves were estimated using the Kaplan-Meier method. RESULTS: Of 171 patients with invasive cancer, 131 (77%) underwent preoperative CRT. The average age was 60 years, and most patients were male (85%). Operations performed included Ivor-Lewis (60%), transhiatal (8%), three-hole (23%), or left thoracoabdominal (8%) esophagectomy. Perioperative mortality rate was 5%. Median overall survival (OS) of the entire group was 33 months, and the 5-year OS rate was 26%. Induction CRT was associated with a 33% 5-year survival rate compared with 11% for surgery alone (P = .43). Patients downstaged to pathologic stage 0 or I had an improved OS and disease-free survival (DFS) compared with those patients who were not downstaged (P = .022). Additionally, the ability to perform an R0 resection was a significant factor for OS and DFS (n = 130; P < .0001 and P <.0002, respectively). CONCLUSION: Response to CRT and the ability to perform an R0 resection are associated with significantly improved survival in patients with esophageal carcinoma. 相似文献
105.
106.
107.
108.
109.
Richard G. Frank Jonathan P. Weiner Donald M. Steinwachs David S. Salkever 《Journal of health economics》1987,6(4):319-337
This study examines the relative impacts of human capital and market conditions on the economic rents associated with hospital privileges in the market for footcare. An empirical model of hospital privileges for podiatrists is formulated based on the Pauly-Redisch model of hospital behavior. The privilege model is then incorporated into a model of podiatrists' earnings via a selection adjustment as proposed by Heckman and Lee. The results indicate the persistance of economic rents even after controlling for unobserved 'quality' factors. 相似文献
110.
Rats were trained in a Y-maze on a two-choice simultaneous brightness discrimination with light as S+ and dark as S- (Stage 1), and were then switched to reversal, where the reinforcement contingencies of the original training were reversed (Stage 2). d-Amphetamine, 1 mg/kg, was administered in a 2 X 2 design, i.e., drug-no drug in Stage 1 and drug-no drug in Stage 2. The administration of the drug in Stage 1 improved the acquisition of the initial brightness discrimination and facilitated reversal learning independently of the drug administered in Stage 2. In addition, the administration of the drug in Stage 2 only improved performance towards the end of reversal training. The results indicate that amphetamine enhances the attention to, or the associability of, the discriminative stimuli, leading to a rapid learning to these stimuli under changed contingencies of reinforcement. 相似文献